Literature DB >> 33141000

Who should be prioritised for COVID-19 vaccination?

Fiona M Russell1,2, Brian Greenwood3.   

Abstract

The development of COVID-19 vaccines is occurring at a rapid pace, with the potential for a vaccine to be available within 6 months. So who should be prioritized for vaccination when in the first instance, there will be insufficient supply to meet demand? There is no doubt that health-care workers in all settings should be vaccinated first, but who comes next will be a complex decision based on local epidemiology, societal values, and the ability of the vaccines to prevent both severe disease and to reduce transmission thereby eliciting herd protection. The decision on who to vaccinate should be equitable, highly contextualized, and based on the property of each vaccine. In some settings, the elderly may be prioritized, in others, it may be the population most likely to get infected and responsible for community spread. To support decision-making on who to be prioritized for vaccination requires urgent additional research on the epidemiology of COVID-19; preexisting immunity and who is responsible for transmission in a variety of settings; the safety, immunogenicity, and efficacy of COVID-19 vaccines in children and pregnant women; and determining whether COVID-19 vaccines prevent asymptomatic infection and transmission.

Entities:  

Keywords:  COVID-19 vaccines; clinical trials; epidemiology; high-risk; transmission; vaccine development

Year:  2020        PMID: 33141000     DOI: 10.1080/21645515.2020.1827882

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  15 in total

1.  A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology.

Authors:  Johann Sellner; Thomas M Jenkins; Tim J von Oertzen; Claudio L Bassetti; Ettore Beghi; Daniel Bereczki; Benedetta Bodini; Francesco Cavallieri; Giovanni Di Liberto; Raimund Helbok; Antonella Macerollo; Luis F Maia; Celia Oreja-Guevara; Serefnur Özturk; Martin Rakusa; Antonio Pisani; Alberto Priori; Anna Sauerbier; Riccardo Soffietti; Pille Taba; Marialuisa Zedde; Michael Crean; Anja Burlica; Alex Twardzik; Elena Moro
Journal:  Eur J Neurol       Date:  2021-02-05       Impact factor: 6.288

2.  The impact of COVID-19 on surgical practice in Jordan during the second outbreak: A survey.

Authors:  Raed M Ennab; Rasheed K Ibdah
Journal:  Ann Med Surg (Lond)       Date:  2021-01-29

3.  Maternal mortality associated with COVID-19 in Brazil in 2020 and 2021: Comparison with non-pregnant women and men.

Authors:  Beatriz Martinelli Menezes Gonçalves; Rossana Pulcinelli V Franco; Agatha S Rodrigues
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

4.  Correlation between vaccine coverage and the COVID-19 pandemic throughout the world: Based on real-world data.

Authors:  Chao Huang; Lijun Yang; Jia Pan; Xiaomei Xu; Rong Peng
Journal:  J Med Virol       Date:  2022-02-04       Impact factor: 20.693

5.  Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Adolescents, Children, and Infants: A Systematic Review and Meta-Analysis.

Authors:  Yuxuan Du; Long Chen; Yuan Shi
Journal:  Front Public Health       Date:  2022-04-14

6.  Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Peng Wang; Jing Ni; Ya-Ya Chu; Qing-Qing Chen; Guo-Cui Wu; Yang Fang; Cong Chen; Ruo-Di Zhang; Ling-Qiong Jiang; Yan Zhao; Xi Fang; Jun He; De-Guang Wang; Gui-Hong Wang; Hai-Feng Pan
Journal:  Biomed Pharmacother       Date:  2022-04-26       Impact factor: 7.419

7.  Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

Authors:  Robert W Frenck; Nicola P Klein; Nicholas Kitchin; Alejandra Gurtman; Judith Absalon; Stephen Lockhart; John L Perez; Emmanuel B Walter; Shelly Senders; Ruth Bailey; Kena A Swanson; Hua Ma; Xia Xu; Kenneth Koury; Warren V Kalina; David Cooper; Timothy Jennings; Donald M Brandon; Stephen J Thomas; Özlem Türeci; Dina B Tresnan; Susan Mather; Philip R Dormitzer; Uğur Şahin; Kathrin U Jansen; William C Gruber
Journal:  N Engl J Med       Date:  2021-05-27       Impact factor: 91.245

8.  Which Group Should be Vaccinated First?: A Systematic Review.

Authors:  Eun Bi Noh; Hae Kweun Nam; Hocheol Lee
Journal:  Infect Chemother       Date:  2021-06

9.  Using Constrained Optimization for the Allocation of COVID-19 Vaccines in the Philippines.

Authors:  Christian Alvin H Buhat; Destiny S M Lutero; Yancee H Olave; Kemuel M Quindala; Mary Grace P Recreo; Dylan Antonio S J Talabis; Monica C Torres; Jerrold M Tubay; Jomar F Rabajante
Journal:  Appl Health Econ Health Policy       Date:  2021-06-25       Impact factor: 2.561

10.  Vaccination Schedule under Conditions of Limited Vaccine Production Rate.

Authors:  Roger Książek; Radosław Kapłan; Katarzyna Gdowska; Piotr Łebkowski
Journal:  Vaccines (Basel)       Date:  2022-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.